| Field | Row 1 |
|---|---|
| adsh | 0001558370-25-007763 |
| cik | 1479419 |
| name | KALA BIO, INC. |
| sic | 2834 |
| countryba | US |
| stprba | MA |
| cityba | ARLINGTON |
| zipba | 02476 |
| bas1 | 1167 MASSACHUSETTS AVENUE |
| bas2 | |
| baph | 781-996-5252 |
| countryma | US |
| stprma | MA |
| cityma | ARLINGTON |
| zipma | 02476 |
| mas1 | 1167 MASSACHUSETTS AVENUE |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 270604595 |
| former | KALA PHARMACEUTICALS, INC. |
| changed | 20091223 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250514 |
| accepted | 2025-05-14 16:22:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | kala-20250331x10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-007763 | 20250331 | Accounts Payable Current | 931000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Business Combination Contingent Consideration Liability Current | 1564000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Common Stock Value | 6000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Earnings Per Share Basic | -1.4100 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Earnings Per Share Diluted | -4.2000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Finance Lease Principal Payments | 28000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Gain Loss On Fair Value Re Measurement Of Contingent Consideration | -158000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20240331 | Interest Paid Net | 1144000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Liabilities | 43151000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Liabilities And Stockholders Equity | 48252000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Liabilities Current | 16956000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Long Term Debt Current | 15503000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Operating Expenses | 10669000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Payment O Cash Portion Of Dosing Milestone | 119000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20231231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; Subsidiary Sale Of Stock= Securities Purchase Agreement2023; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; Subsidiary Sale Of Stock= Third Securities Purchase Agreement2024; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Issued | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Outstanding | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Prepaid Expense And Other Assets Current | 3495000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Stockholders Equity | 682569000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Stockholders Equity | -676867000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Shares New Issues Conversion Of Series E Preferred Stock | 8538000.0000 | USD | 1 | 0001558370-25-007763 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Additional Paid In Capital | 682569000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Business Combination Contingent Consideration Liability Noncurrent | 3116000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 42222000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -8959000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007763 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -378000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Investment Income Interest | 504000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Liabilities And Stockholders Equity | 55483000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Net Cash Provided By Used In Financing Activities | 8440000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Net Cash Provided By Used In Financing Activities | -135000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Net Cash Provided By Used In Operating Activities | -8824000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Payments To Acquire Property Plant And Equipment And Other Assets | 13000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Issued | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Issued | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Outstanding | 9393.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Outstanding | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Outstanding | 3286.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Shares Outstanding | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Shares Outstanding | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Shares Outstanding | 3286.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Shares Outstanding | 6452398.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20240331 | Stockholders Equity | 647874000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Stockholders Equity | 5708000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 2813210.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Accrued Issuance Costs | 62000.0000 | USD | 0 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20250331 | Assets Current | 45717000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 51181000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Accounts Payable Current | 628000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Increase Decrease In Accrued Liabilities | -881000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Accrued Liabilities And Other Liabilities | 4038000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Amortization Of Financing Costs And Discounts | 312000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Assets | 55483000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Business Combination Contingent Consideration Liability Noncurrent | 4659000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Cash And Cash Equivalents At Carrying Value | 42222000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -2417000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Deferred Income Current | 637000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Depreciation Depletion And Amortization | 68000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Gain Loss On Fair Value Re Measurement Of Contingent Consideration | -21000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20240331 | General And Administrative Expense | 5422000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | General And Administrative Expense | 5422000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reporting Segment; | ||
| 0001558370-25-007763 | 20240331 | Increase Decrease In Accounts Payable | -187000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Increase Decrease In Accrued Liabilities | -2164000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Increase Decrease In Lease And Other Liabilities Noncurrent | -88000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20250331 | Increase Decrease In Other Noncurrent Assets | 7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Net Income Loss | -8947000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Net Income Loss Available To Common Stockholders Basic | -8947000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Net Income Loss Available To Common Stockholders Basic | -8947000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reporting Segment; | ||
| 0001558370-25-007763 | 20241231 | Operating Lease Liability Current | 380000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20230430 | Operating Lease Right Of Use Asset | 2154000.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Menlo Park California Office Lease; | ||
| 0001558370-25-007763 | 20240331 | Payments Of Stock Issuance Costs Temporary Equity | 62000.0000 | USD | 1 | 0001558370-25-007763 | Subsidiary Sale Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; Subsidiary Sale Of Stock= Securities Purchase Agreement2024; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Issued | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Issued | 3286.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Outstanding | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007763 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 13000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Profit Loss | -8947000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Research And Development Expense | 6351000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Research And Development Expense | 6055000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Restricted Cash And Other Assets Noncurrent | 246000.0000 | USD | 0 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20250331 | Retained Earnings Accumulated Deficit | -676867000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Shares Outstanding | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Shares Outstanding | 9393.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20231231 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20250331 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 2302.0000 | shares | 1 | us-gaap/2024 | Award Type= Employee Stock Purchase Plan; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Value Issued For Services | 29000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Income From Grants | 2350000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20250331 | Investment Income Interest | 463000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Net Cash Provided By Used In Investing Activities | -13000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Non Cash Operating Lease | 90000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20240331 | Nonoperating Income Expense | 124000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Operating Lease Right Of Use Asset | 1601000.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Menlo Park California Office Lease; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Issued | 3286.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Outstanding | 6409.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007763 | 20240331 | Profit Loss | -11807000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Share Based Compensation | 2310000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20231231 | Shares Outstanding | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Shares Outstanding | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Stockholders Equity | -667920000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 21000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6345869.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Operating Lease Right Of Use Asset | 1601000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2376000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2310000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 50895000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 48478000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Common Stock Shares Issued | 6091182.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Common Stock Shares Outstanding | 6091182.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Common Stock Value | 6000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Comprehensive Income Net Of Tax | -11807000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Earnings Per Share Diluted | -1.4100 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Expense Related To Distribution Or Servicing And Underwriting Fees | 62000.0000 | USD | 1 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Income From Grants | 1075000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20250331 | Income From Grants | 2350000.0000 | USD | 1 | 0001558370-25-007763 | Counterparty Name= California Institute For Regenerative Medicine; Legal Entity= Combangio Inc; Type Of Arrangement= Award Agreement; | ||
| 0001558370-25-007763 | 20240331 | Interest Expense Nonoperating | 1455000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Long Term Debt Current | 10336000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Long Term Debt Noncurrent | 20102000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Long Term Debt Noncurrent | 15121000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Net Income Loss | -8947000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007763 | 20250331 | Nonoperating Income Expense | 1722000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Operating Expenses | 11931000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240630 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; Subsidiary Sale Of Stock= Second Securities Purchase Agreement2024; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Issued | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Outstanding | 3286.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Shares Outstanding | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Shares Outstanding | 6091182.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20250331 | Shares Outstanding | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20240331 | Stockholders Equity | -641216000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007763 | 20241231 | Stockholders Equity | 12332000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Stockholders Equity | 680246000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 298400.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 2302.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Value Issued For Services | 29000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6345869.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 2813210.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Accrued Liabilities And Other Liabilities | 4975000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007763 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Common Stock Shares Authorized | 120000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Depreciation Depletion And Amortization | 66000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Earnings Per Share Basic | -4.2000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1879000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Interest Expense Nonoperating | 1456000.0000 | USD | 1 | us-gaap/2024 | Credit Facility= Athyrium Credit Facility; | ||
| 0001558370-25-007763 | 20250331 | Interest Expense Nonoperating | 1091000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Interest Expense Nonoperating | 1087000.0000 | USD | 1 | us-gaap/2024 | Credit Facility= Athyrium Credit Facility; | ||
| 0001558370-25-007763 | 20240331 | Net Income Loss | -11807000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Non Cash Operating Lease | 80000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20240331 | Operating Income Loss | -11931000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Operating Income Loss | -10669000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Operating Lease Right Of Use Asset | 1691000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Other Noncash Income Expense | -17000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Outstanding | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Outstanding | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Proceeds From Issuance Of Preferred Stock And Preference Stock | 8538000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Shares Outstanding | 2816454.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20250331 | Shares Outstanding | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Shares Outstanding | 3286.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series I Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20231231 | Stockholders Equity | -629409000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Shares Conversion Of Convertible Securities | -2984.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Shares Issued For Services | 4000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 49503.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 60514.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20241231 | Additional Paid In Capital | 680246000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2310000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Amortization Of Financing Costs And Discounts | 186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Assets | 48252000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Cash And Cash Equivalents At Carrying Value | 51181000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Comprehensive Income Net Of Tax | -8947000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | General And Administrative Expense | 4593000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reporting Segment; | ||
| 0001558370-25-007763 | 20250331 | Increase Decrease In Accounts Payable | 303000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Increase Decrease In Lease And Other Liabilities Noncurrent | -73000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20250331 | Liabilities | 42544000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Liabilities Current | 22975000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Net Income Loss | -11807000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007763 | 20240331 | Net Income Loss Available To Common Stockholders Basic | -11807000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Net Income Loss Available To Common Stockholders Basic | -11807000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reporting Segment; | ||
| 0001558370-25-007763 | 20250331 | Operating Lease Liability Current | 393000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Operating Lease Liability Noncurrent | 1434000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Issued | 51246.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Preferred Stock Shares Issued | 9393.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Outstanding | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20241231 | Prepaid Expense And Other Assets Current | 1616000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Prepaid Expense And Other Assets Current | 2260000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Prepaid Expenses And Other Current Asset; | ||
| 0001558370-25-007763 | 20241231 | Property Plant And Equipment Net | 749000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Property Plant And Equipment Net | 695000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Restricted Cash And Other Assets Noncurrent | 239000.0000 | USD | 0 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20241231 | Retained Earnings Accumulated Deficit | -667920000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20231231 | Shares Outstanding | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20231231 | Shares Outstanding | 2759372.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20231231 | Stockholders Equity | 7504000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Stockholders Equity | 6661000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Shares New Issues Conversion Of Series E Preferred Stock | 8538000.0000 | USD | 1 | 0001558370-25-007763 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 13000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 13000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20241231 | Assets Current | 52797000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Common Stock Shares Authorized | 120000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Common Stock Shares Issued | 6452398.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Common Stock Shares Outstanding | 6452398.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Deferred Income Current | 546000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | General And Administrative Expense | 4593000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Income From Grants | 1075000.0000 | USD | 1 | 0001558370-25-007763 | Counterparty Name= California Institute For Regenerative Medicine; Legal Entity= Combangio Inc; Type Of Arrangement= Award Agreement; | ||
| 0001558370-25-007763 | 20250331 | Interest Paid Net | 909000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20241231 | Liabilities Noncurrent | 26195000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Liabilities Noncurrent | 19569000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Net Cash Provided By Used In Operating Activities | -10844000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Operating Lease Liability Noncurrent | 1332000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20250331 | Preferred Stock Shares Issued | 6409.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Proceeds From Issuance Of Common Stock And Series I Preferred Stock | -120000.0000 | USD | 1 | 0001558370-25-007763 | |||
| 0001558370-25-007763 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Share Based Compensation | 2376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007763 | 20240331 | Shares Outstanding | 2928.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Shares Outstanding | 10901.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series G Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20250331 | Shares Outstanding | 6409.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series H Non Redeemable Non Controlling Preferred Stock; | ||
| 0001558370-25-007763 | 20231231 | Stockholders Equity | 636910000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007763 | 20240331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 3579.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Deferred Income Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income, Current | Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
| Payment O Cash Portion Of Dosing Milestone | 0001558370-25-007763 | 1 | 0 | monetary | D | C | Payment O Cash Portion Of Dosing Milestone | The amount of cash outflow for cash portion of dosing milestone. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Stock Issued During Period Shares Issued For Services | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Proceeds From Issuance Of Common Stock And Series I Preferred Stock | 0001558370-25-007763 | 1 | 0 | monetary | D | D | Proceeds From Issuance Of Common Stock And Series I Preferred Stock | The cash inflow from the issuance of common stock and series I preferred stock. |
| Restricted Cash And Other Assets Noncurrent | 0001558370-25-007763 | 1 | 0 | monetary | I | D | Restricted Cash And Other Assets Noncurrent | Amount of cash and other long-term assets restricted as to withdrawal or usage, classified as noncurrent. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Accrued Liabilities And Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. |
| Business Combination Contingent Consideration Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Business Combination, Contingent Consideration, Liability, Current | Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Proceeds From Issuance Of Preferred Stock And Preference Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Preferred Stock and Preference Stock | Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Business Combination Contingent Consideration Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Business Combination, Contingent Consideration, Liability, Noncurrent | Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. |
| Expense Related To Distribution Or Servicing And Underwriting Fees | us-gaap/2024 | 0 | 0 | monetary | D | D | Expense Related to Distribution or Servicing and Underwriting Fees | Expense related to distribution, servicing and underwriting fees. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Finance Lease Principal Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
| Stock Issued During Period Value Issued For Services | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
| Payments Of Stock Issuance Costs Temporary Equity | 0001558370-25-007763 | 1 | 0 | monetary | D | C | Payments of Stock Issuance Costs, Temporary Equity | The cash outflow for cost incurred directly with the issuance of temporary equity. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Net Income Loss Available To Common Stockholders Basic | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Gain Loss On Fair Value Re Measurement Of Contingent Consideration | 0001558370-25-007763 | 1 | 0 | monetary | D | C | (Gain) Loss on Fair Value Re-measurement of Contingent Consideration | Amount of (gain) loss recognized on fair value adjustment of contingent consideration. |
| Non Cash Operating Lease | 0001558370-25-007763 | 1 | 0 | monetary | D | D | Non Cash Operating Lease | Amount of non-cash operating lease cost. |
| Stock Issued During Period Shares New Issues Conversion Of Series E Preferred Stock | 0001558370-25-007763 | 1 | 0 | monetary | D | C | Stock Issued During Period Shares New Issues Conversion Of Series E Preferred Stock | Number of new stock issued during the period from the conversion of Series E Preferred Stock. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | |
| Accrued Issuance Costs | 0001558370-25-007763 | 1 | 0 | monetary | I | C | Accrued Issuance Costs | Carrying value as of the balance sheet date of obligations incurred through that date and payable for issuance costs. |
| Increase Decrease In Lease And Other Liabilities Noncurrent | 0001558370-25-007763 | 1 | 0 | monetary | D | D | Increase Decrease In Lease And Other Liabilities, Noncurrent | The increase (decrease) during the reporting period in lease and noncurrent liabilities. |
| Payments To Acquire Property Plant And Equipment And Other Assets | 0001558370-25-007763 | 1 | 0 | monetary | D | C | Payments To Acquire Property Plant And Equipment And Other Assets | The cash outflow associated with the acquisition of long-lived, physical and other assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Long Term Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Income From Grants | 0001558370-25-007763 | 1 | 0 | monetary | D | C | Income From Grants | Amount of grant income. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-007763 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001558370-25-007763 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001558370-25-007763 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001558370-25-007763 | 2 | 7 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001558370-25-007763 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right-of-use assets | 0 |
| 0001558370-25-007763 | 2 | 9 | BS | 0 | H | Restricted Cash And Other Assets Noncurrent | 0001558370-25-007763 | Other long-term assets | 0 |
| 0001558370-25-007763 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001558370-25-007763 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001558370-25-007763 | 2 | 14 | BS | 0 | H | Accrued Liabilities And Other Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0001558370-25-007763 | 2 | 15 | BS | 0 | H | Deferred Income Current | us-gaap/2024 | Deferred grant income | 0 |
| 0001558370-25-007763 | 2 | 16 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of lease liabilities | 0 |
| 0001558370-25-007763 | 2 | 17 | BS | 0 | H | Long Term Debt Current | us-gaap/2024 | Current portion of long-term debt | 0 |
| 0001558370-25-007763 | 2 | 18 | BS | 0 | H | Business Combination Contingent Consideration Liability Current | us-gaap/2024 | Current portion of contingent consideration | 0 |
| 0001558370-25-007763 | 2 | 19 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001558370-25-007763 | 2 | 21 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Long-term lease liabilities | 0 |
| 0001558370-25-007763 | 2 | 22 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Long-term debt, net of current portion | 0 |
| 0001558370-25-007763 | 2 | 23 | BS | 0 | H | Business Combination Contingent Consideration Liability Noncurrent | us-gaap/2024 | Long-term contingent consideration | 0 |
| 0001558370-25-007763 | 2 | 24 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total long-term liabilities | 0 |
| 0001558370-25-007763 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001558370-25-007763 | 2 | 26 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and Contingencies (Note 14) | 0 |
| 0001558370-25-007763 | 2 | 28 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value; 5,000,000 shares authorized as of September 30, 2024 and December 31, 2023 | 0 |
| 0001558370-25-007763 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value; 120,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 4,610,139 and 2,759,372 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | 0 |
| 0001558370-25-007763 | 2 | 30 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001558370-25-007763 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001558370-25-007763 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0001558370-25-007763 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0001558370-25-007763 | 3 | 10 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001558370-25-007763 | 3 | 11 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, authorized | 0 |
| 0001558370-25-007763 | 3 | 12 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001558370-25-007763 | 3 | 13 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001558370-25-007763 | 3 | 14 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001558370-25-007763 | 3 | 15 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, authorized | 0 |
| 0001558370-25-007763 | 3 | 16 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001558370-25-007763 | 3 | 17 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001558370-25-007763 | 4 | 2 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001558370-25-007763 | 4 | 3 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001558370-25-007763 | 4 | 4 | IS | 0 | H | Gain Loss On Fair Value Re Measurement Of Contingent Consideration | 0001558370-25-007763 | Loss (gain) on fair value remeasurement of contingent consideration | 1 |
| 0001558370-25-007763 | 4 | 5 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total costs and expenses | 0 |
| 0001558370-25-007763 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001558370-25-007763 | 4 | 8 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0001558370-25-007763 | 4 | 9 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001558370-25-007763 | 4 | 10 | IS | 0 | H | Income From Grants | 0001558370-25-007763 | Grant income | 0 |
| 0001558370-25-007763 | 4 | 12 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (expense) | 0 |
| 0001558370-25-007763 | 4 | 13 | IS | 0 | H | Net Income Loss Available To Common Stockholders Basic | us-gaap/2024 | Net loss | 0 |
| 0001558370-25-007763 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share attributable to common stockholders-basic (in dollar per share) | 0 |
| 0001558370-25-007763 | 4 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share attributable to common stockholders-diluted (in dollar per share) | 0 |
| 0001558370-25-007763 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding-basic (in shares) | 0 |
| 0001558370-25-007763 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average common shares outstanding -diluted (in shares) | 0 |
| 0001558370-25-007763 | 4 | 19 | IS | 0 | H | Net Income Loss Available To Common Stockholders Basic | us-gaap/2024 | Net loss | 0 |
| 0001558370-25-007763 | 4 | 21 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss | 0 |
| 0001558370-25-007763 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance as of beginning of period | 0 |
| 0001558370-25-007763 | 5 | 17 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance as of beginning of period (in shares) | 0 |
| 0001558370-25-007763 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Issuance of common stock for vested restricted stock units (in shares) | 0 |
| 0001558370-25-007763 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | Issuance of common stock under employee stock purchase plan | 0 |
| 0001558370-25-007763 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | Issuance of common stock under employee stock purchase plan (in shares) | 0 |
| 0001558370-25-007763 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2024 | Issuance of common stock to satisfy service contract | 0 |
| 0001558370-25-007763 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Shares Issued For Services | us-gaap/2024 | Issuance of common stock to satisfy service contract (in shares) | 0 |
| 0001558370-25-007763 | 5 | 28 | EQ | 0 | H | Stock Issued During Period Shares New Issues Conversion Of Series E Preferred Stock | 0001558370-25-007763 | Issuance of common stock upon conversion of Series E preferred stock | 0 |
| 0001558370-25-007763 | 5 | 30 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Issuance of common stock upon conversion of Preferred Stock (in shares) | 0 |
| 0001558370-25-007763 | 5 | 31 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0001558370-25-007763 | 5 | 32 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0001558370-25-007763 | 5 | 33 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance as of end of period | 0 |
| 0001558370-25-007763 | 5 | 34 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance as of end of period (in shares) | 0 |
| 0001558370-25-007763 | 6 | 6 | EQ | 1 | H | Expense Related To Distribution Or Servicing And Underwriting Fees | us-gaap/2024 | Issuance costs | 0 |
| 0001558370-25-007763 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001558370-25-007763 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001558370-25-007763 | 7 | 5 | CF | 0 | H | Non Cash Operating Lease | 0001558370-25-007763 | Non-cash operating lease cost | 0 |
| 0001558370-25-007763 | 7 | 7 | CF | 0 | H | Gain Loss On Fair Value Re Measurement Of Contingent Consideration | 0001558370-25-007763 | Loss (gain) on fair value remeasurement of contingent consideration | 1 |
| 0001558370-25-007763 | 7 | 8 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization of debt discount and other non-cash interest | 0 |
| 0001558370-25-007763 | 7 | 9 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001558370-25-007763 | 7 | 10 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Other non-cash losses (gains) | 1 |
| 0001558370-25-007763 | 7 | 12 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001558370-25-007763 | 7 | 13 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other long-term assets | 1 |
| 0001558370-25-007763 | 7 | 14 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001558370-25-007763 | 7 | 15 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0001558370-25-007763 | 7 | 16 | CF | 0 | H | Increase Decrease In Lease And Other Liabilities Noncurrent | 0001558370-25-007763 | Lease liabilities and other long-term liabilities | 0 |
| 0001558370-25-007763 | 7 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001558370-25-007763 | 7 | 19 | CF | 0 | H | Payments To Acquire Property Plant And Equipment And Other Assets | 0001558370-25-007763 | Purchases of property and equipment and other assets | 1 |
| 0001558370-25-007763 | 7 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001558370-25-007763 | 7 | 22 | CF | 0 | H | Proceeds From Issuance Of Preferred Stock And Preference Stock | us-gaap/2024 | Proceeds from issuance of preferred stock, net of issuance costs | 0 |
| 0001558370-25-007763 | 7 | 23 | CF | 0 | H | Proceeds From Issuance Of Common Stock And Series I Preferred Stock | 0001558370-25-007763 | Proceeds from issuance of common stock and Series I preferred stock | 0 |
| 0001558370-25-007763 | 7 | 24 | CF | 0 | H | Payment O Cash Portion Of Dosing Milestone | 0001558370-25-007763 | Contingent consideration related to Combangio acquisition | 1 |
| 0001558370-25-007763 | 7 | 25 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2024 | Payment of principal on finance lease | 1 |
| 0001558370-25-007763 | 7 | 26 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | Proceeds from issuance of common stock under employee stock purchase plan | 0 |
| 0001558370-25-007763 | 7 | 27 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001558370-25-007763 | 7 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash and cash equivalents: | 0 |
| 0001558370-25-007763 | 7 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001558370-25-007763 | 7 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001558370-25-007763 | 7 | 32 | CF | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2024 | Issuance of common stock to satisfy service contract in additional paid-in capital | 0 |
| 0001558370-25-007763 | 7 | 33 | CF | 0 | H | Accrued Issuance Costs | 0001558370-25-007763 | Issuance costs included in accrued expenses | 0 |
| 0001558370-25-007763 | 7 | 35 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001558370-25-007763 | 8 | 6 | CF | 1 | H | Payments Of Stock Issuance Costs Temporary Equity | 0001558370-25-007763 | Preferred stock issuance costs | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |